Submit your results here: https://go.usa.gov/xSc6t
Originally posted by alyse_c
View Post
-
Tomorrow is the last day to submit your results for the NCTR Indel Calling from Oncopanel Sequencing Data Challenge! Phase 1 closes on July 8th. The optional Phase 2 is open for only those who have completed Phase 1 and will run from July 11th-July 26th.
Submit your results here: https://go.usa.gov/xSc6t
-
There are only a few days left to submit your results for the NCTR Indel Calling from Oncopanel Sequencing Data Challenge! Phase 1 closes on July 8th. Those who completed Phase 1 for both Oncopanel A & Oncopanel B will be able to participate in the optional Phase 2 that runs from July 11th-July 26th.
Visit the site below to submit your final results!
https://go.usa.gov/xJzdB
Originally posted by alyse_c View PostLeave a comment:
-
PrecisionFDA's NCTR Indel Calling from Oncopanel Sequencing Data Challenge
Reminder! We are less than one month out from the NCTR Indel Calling from Oncopanel Sequencing Data Challenge submission deadline! There’s still time to join the challenge.
This challenge is being hosted in collaboration with the FDA’s National Center for Toxicological Research (NCTR) and is taking part in two phases.
Phase 1 of the challenge will run through July 8th and Phase 2 will run from July 11th-July 26th.
The primary goal of this challenge is to encourage the bioinformatics community to develop, validate, and benchmark indel calling pipelines to identify indels in oncopanel sequencing datasets. Given the widely recognized impact of indels on protein coding and function, it is crucial that the tools for indel-calling be rigorously evaluated and optimized.
Winners of the challenge will be publicly recognized and invited to contribute to a manuscript and a webinar describing the challenge and their submission results. Visit the challenge site below to get started or to submit your results!
https://go.usa.gov/xJw8BLast edited by alyse_c; 06-22-2022, 01:18 PM.
-
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...04-04-2024, 04:25 PM -
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...03-22-2024, 06:39 AM
Leave a comment: